https://ift.tt/2LoHaks Gilead Sciences has struck a licensing agreement with five generic drugmakers to make antiviral drug remdesivir in 127 countries, not including the United States. The deal is “royalty-free” until WHO says the Covid-19 outbreak is no longer a global health crisis